By Theresa Curry Early next year, biopharmaceutical company Priovant Therapeutics, an affiliate of Roivant Sciences, plans to file for FDA approval of brepocitinib. If approved, the drug could become the…
Continue Reading
TMA and MDA Partner to Fund Yale Research on Immune Dysfunction in IBM
Columbia, MD — December 3, 2025 — The Myositis Association (TMA) is proud to announce a new research partnership with the Muscular Dystrophy Association (MDA) to co-fund a groundbreaking study…
Continue Reading
TMA Funding Supports Early Career Researcher
By Begum Horuluoglu, PhD Thanks to the generous support of The Myositis Association (TMA), I have been able to pursue groundbreaking research into the immunological mechanisms underlying idiopathic inflammatory myopathies,…
Continue Reading
Nobel Prize for Autoimmunity Advances Brings Hope to Those with Myositis
This year’s Nobel Prize in Physiology or Medicine was awarded to three scientists—Mary E. Brunkow, Frederick J. Ramsdell, and Shimon Sakaguchi—for discoveries that help explain why the immune system sometimes…
Continue Reading
New Study Reveals Impact of Inclusion Body Myositis on US Veterans
A newly published study by Dr. Vladimir M. Liarski in the journal Military Medical Research offers the most comprehensive analysis to date of inclusion body myositis (IBM) among US veterans. Drawing on data from the Veterans Administration…
Continue Reading